ARCHIVES

Sanofi: Zaltrap Price Reflects Competing Drugs In Second-Line Metastatic Colon Cancer

This article is from The Cancer Letter archive.

Vol. 38 No. 41 | November 1, 2012

Download PDF Visit The Full Archive

Related Articles

Cancer Screenings: American Over 50 Urged to Get Colon Caner Tests

March 5, 1999

In Brief: Fischinger, SAIC Win $400 Million Contract

March 3, 1995

NCI Director and Acting FDA Commissioner Andrew von Eschenbach Endorses Rep. E. Clay Shaw In Tour of Florida Congressman’s District. Von Eschenbach Praises Shaw’s “Leadership” In Seeking Funding For Research, Support of 2015 Goal.

February 3, 2006

In Brief: DOD Bill includes $135M For breast Cancer, $45M For prostate Cancer Technologies

October 3, 1997

Northwestern To Test Method To Detect Colon Cancer

February 25, 2005

Campath Improves PFS In B-Cell CLL In Phase III Trial

January 26, 2007